Stocks
Organon Financial Statements (OGN) |
||||||||||
| Organonsmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 05.05.2023 | 09.08.2023 | 03.11.2023 | 26.02.2024 | 03.05.2024 | 03.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 538 | 1 608 | 1 519 | 1 598 | 1 622 | 6 347 | |||
| Operating Income, bln rub | 331.0 | 0.389 | 0.232 | 312.0 | 414.0 | 726.6 | ||||
| EBITDA, bln rub | ? | 388.0 | 388.0 | 228.0 | 370.0 | 479.0 | 1 465 | |||
| Net profit, bln rub | ? | 177.0 | 242.0 | 58.0 | 546.0 | 201.0 | 1 047 | |||
| OCF, bln rub | ? | 114.0 | 27.0 | 261.0 | 397.0 | 76.0 | 761.0 | |||
| CAPEX, bln rub | ? | 54.0 | 71.0 | 55.0 | 81.0 | 46.0 | 253.0 | |||
| FCF, bln rub | ? | 60.0 | -44.0 | 206.0 | 316.0 | 30.0 | 508.0 | |||
| Dividend payout, bln rub | 73.0 | 74.0 | 74.0 | 73.0 | 70.0 | 291.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 41.2% | 30.6% | 127.6% | 13.4% | 34.8% | 27.8% | ||||
| OPEX, bln rub | 564.0 | 579.0 | 675.0 | 603.0 | 543.0 | 2 400 | ||||
| Cost of production, bln rub | 580.0 | 640.0 | 612.0 | 683.0 | 665.0 | 2 600 | ||||
| R&D, bln rub | 129.0 | 128.0 | 137.0 | 134.0 | 112.0 | 511.0 | ||||
| Interest expenses, bln rub | 132.0 | 132.0 | 134.0 | 129.0 | 131.0 | 526.0 | ||||
| Assets, bln rub | 10 763 | 10 979 | 11 012 | 12 058 | 11 891 | 11 891 | ||||
| Net Assets, bln rub | ? | -737.0 | -555.0 | -589.0 | -70.0 | 48.0 | 48.0 | |||
| Debt, bln rub | 8 711 | 8 730 | 8 654 | 8 760 | 8 714 | 8 714 | ||||
| Cash, bln rub | 459.0 | 326.0 | 414.0 | 693.0 | 575.0 | 575.0 | ||||
| Net debt, bln rub | 8 252 | 8 404 | 8 240 | 8 067 | 8 139 | 8 139 | ||||
| Ordinary share price, rub | 23.5 | 20.8 | 17.4 | 14.4 | 18.8 | 30.5 | ||||
| Number of ordinary shares, mln | 254.4 | 255.3 | 255.6 | 255.6 | 255.7 | 255.7 | ||||
| Market cap, bln rub | 5 983 | 5 314 | 4 437 | 3 686 | 4 807 | 7 799 | ||||
| EV, bln rub | ? | 14 235 | 13 718 | 12 677 | 11 753 | 12 946 | 15 938 | |||
| Book value, bln rub | -5 961 | -5 750 | -5 753 | -5 206 | -5 273 | -5 273 | ||||
| EPS, rub | ? | 0.70 | 0.95 | 0.23 | 2.14 | 0.79 | 4.09 | |||
| FCF/share, rub | 0.24 | -0.17 | 0.81 | 1.24 | 0.12 | 1.99 | ||||
| BV/share, rub | -23.4 | -22.5 | -22.5 | -20.4 | -20.6 | -20.6 | ||||
| EBITDA margin, % | ? | 25.2% | 24.1% | 15.0% | 23.2% | 29.5% | 23.1% | |||
| Net margin, % | ? | 11.5% | 15.0% | 3.82% | 34.2% | 12.4% | 16.5% | |||
| FCF yield, % | ? | 7.20% | 6.02% | 9.56% | 14.6% | 10.6% | 6.51% | |||
| ROE, % | ? | -101.2% | -135.9% | -99.3% | -1 461% | 2 181% | 2 181% | |||
| ROA, % | ? | 6.93% | 6.87% | 5.31% | 8.48% | 8.80% | 8.80% | |||
| P/E | ? | 8.02 | 7.05 | 7.58 | 3.60 | 4.59 | 7.45 | |||
| P/FCF | 13.9 | 16.6 | 10.5 | 6.85 | 9.46 | 15.4 | ||||
| P/S | ? | 0.97 | 0.86 | 0.72 | 0.59 | 0.76 | 1.23 | |||
| P/BV | ? | -1.00 | -0.92 | -0.77 | -0.71 | -0.91 | -1.48 | |||
| EV/EBITDA | ? | 9.10 | 9.33 | 9.88 | 8.55 | 8.84 | 10.9 | |||
| Debt/EBITDA | 5.28 | 5.72 | 6.42 | 5.87 | 5.56 | 5.56 | ||||
| R&D/CAPEX, % | 238.9% | 180.3% | 249.1% | 165.4% | 243.5% | 202.0% | ||||
| CAPEX/Revenue, % | 3.51% | 4.42% | 3.62% | 5.07% | 2.84% | 3.99% | ||||
| Organon shareholders | ||||||||||
